Condition

Hairy Cell Leukemia clinical trials and research

• 8Clinical trials
• 2Countries

Newest Hairy Cell Leukemia clinical trials

All recruiting trials (8)

• Tovorafenib plus rituximab for classical hairy cell leukemia

  This trial tests whether combining tovorafenib and rituximab is safe and effective for adults with relapsed or refractory classical hairy cell leukemia and compares that combination to cladribine plus rituximab in newly diagnosed patients.

  Recruiting at 4 sites Phase 1/2 National Cancer Institute (NCI) · Bethesda, Maryland and 3 other locations · NCT06965114

• Comparing two treatment combinations for Hairy Cell Leukemia

  This study is testing whether a new combination of drugs can work better and cause fewer side effects than the standard treatment for patients with Hairy Cell Leukemia who have a specific genetic mutation.

  Recruiting at 8 sites Phase 2 Memorial Sloan Kettering Cancer Center · Boston, Massachusetts and 9 other locations · NCT06561360

• Using CAR T cells to treat certain types of B cell lymphomas

  This study is testing a new CAR T cell therapy to see if it can help adults with certain types of B cell lymphomas that haven't improved with other treatments.

  Recruiting Phase 1 Stanford University · Palo Alto, California · NCT06340737

• Using modified T cells to treat relapsed hairy cell leukemia

  This study is testing a new treatment using modified T cells to see if it can help adults with relapsed hairy cell leukemia who haven't responded to other therapies.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT04815356

• Oral treatment with LP-168 for patients with certain blood cancers

  This study is testing an oral treatment called LP-168 to see if it can help adults with certain types of blood cancers that have come back or didn't respond to other treatments.

  Recruiting at 4 sites Phase 1 Newave Pharmaceutical Inc · Durham, North Carolina and 3 other locations · NCT04775745

• Treatment for Hairy Cell Leukemia Without BRAF Mutation

  This study is testing if a new drug called binimetinib can help people with hairy cell leukemia who don't have a BRAF mutation and haven't responded to other treatments.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT04322383

• Optimizing treatment for hairy cell leukemia with cladribine injections

  This study is testing if a single round of cladribine injections can help people with untreated hairy cell leukemia go into remission.

  Recruiting at 75 sites Phase 2/3 University of Giessen · Ansbach and 75 other locations · NCT02131753

• Combining cladribine and rituximab to treat hairy cell leukemia

  This study is testing if combining two drugs, cladribine and rituximab, can effectively treat hairy cell leukemia, especially in patients whose cancer has come back.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT00412594

Related topics

Quick answers

How many Hairy Cell Leukemia clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (7 trials), Germany (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 1: 3, Phase 2/3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →